PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Hematology, Department of Medicine, The Ohio State University, Columbus, OH, USA. Michael.grever@osumc.edu.\', \'Division of Hematology Oncology, University of New Mexico Comprehensive Cancer Center, Albuquerque, NM, USA.\', \'Department of Internal Medicine & Biochemistry and Medical Genetics, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada.\', \'Research Institute in Oncology and Hematology, CancerCare Manitoba, Winnipeg, MB, Canada.\', \'Department of Medicine, Northwell Health Cancer Institute, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and Feinstein Institute for Medical Research, New York, NY, USA.\', \'Division of Hematology, Department of Medicine, The Ohio State University, Columbus, OH, USA.\', \'Division of Hematology, Mayo Clinic, Rochester, MN, USA.\', \'Royal Marsden Hospital, London, UK.\', \'Department of Internal Medicine and Oncology, Semmelweis University, Budapest, Hungary.\', \'Department of Hematology, University Hospital, Heidelberg, Germany.\', \'Institute of Hematology, Department of Medicine and Surgery, University and Hospital of Perugia, Perugia, Italy.\', \'Cancer Sciences and Haematology Department, University of Southampton Hospital Trust, Southampton, UK.\', \'Johns Hopkins University, Baltimore, MD, USA.\', \'University of Siena Policlinico S Maria alle Scotte, Siena, Italy.\', \'Department of Internal Medicine, University of Manitoba, Winnipeg, MB, Canada.\', \'Stem Cell Centre, Department of Laboratory Medicine, Lund University, and Department of Hematology, Skåne University Hospital, Lund, Sweden.\', \'Laboratory of Molecular Biology, National Cancer Institute, NIH, Bethesda, MD, USA.\', \'Department of Pathology, The Ohio State University Medical Center, Columbus, OH, USA.\', \'Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.\', \'Hadassah-Hebrew University Medical Center, Jerusalem, Israel.\', \'Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.\', \'Department of Hematology, Medical University of Lodz, Lodz, Poland.\', \'Division of Hematology and Oncology, Scripps Clinic, La Jolla, CA, USA.\', \'Haematology Department, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, University of Melbourne, Melbourne, VIC, Australia.\', \'Hematology Unit, Bnai-Zion Medical Center and Rappaport Faculty of Medicine, Technion Institute Technology, Haifa, Israel.\', \'Department of Hematology, Centre Hospitalier Universitaire Côte de Nacre, Caen, France.\', \'James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY, USA.\', \'Department of Medical Oncology and Haematology, University Hospital Zürich and University of Zürich, Zürich, Switzerland.\', \'IRCCS Azienda Ospedaliero-Universitaria di Bologna and Instituto di Ematologia \'Seràgnoli\', Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale Università degli Studi, Bologna, Italy.\', \'Charité-University Medicine, Berlin, Germany. bernhar.woermann@charite.de.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41375-021-01257-7
?:hasPublicationType
?:journal
  • Leukemia
is ?:pmid of
?:pmid
?:pmid
  • 33947938
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 5.131
?:rankingScore_hIndex
  • 168
?:title
  • Hairy cell leukemia and COVID-19 adaptation of treatment guidelines.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all